Watchlist Price Alert

Apimeds Pharmaceuticals U... (APUS)

NYSE: APUS · Real-Time Price · USD

1.72

0.09 (5.52%)

At close: Jun 23, 2025, 3:51 PM

1.72

0.00%

After-hours: Jun 23, 2025, 05:05 PM EDT

Apimeds Pharmaceuticals US Inc Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Net Income	-1.39M	-1.65M	-1.42M	-1.01M	-777.69K	-285.32K	-175.3K	-139.23K	-74.59K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	-1	22.44K	69.99K	118.38K	118.38K	95.94K	48.39K
Other Working Capital	538.75K	575.69K	291.99K	48.31K	41.84K	-173.23K	-2.66K	-2.15K	-2.15K
Other Non-Cash Items	117.72K	95.15K	70.6K	56.73K	38.07K	33K	24.91K	16.66K	8.41K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	538.75K	575.69K	291.99K	48.31K	41.84K	-173.23K	-2.66K	-2.15K	-2.15K
Operating Cash Flow	-733.53K	-974.48K	-1.06M	-882.06K	-627.79K	-307.17K	-34.67K	-28.78K	-19.95K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	150K	150K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	176.5K	-455K	568.1K	468.1K	477.1K	1.31M	291.9K	291.9K	282.9K
Financial Cash Flow	326.5K	250K	1.12M	1.02M	1.03M	1.31M	291.9K	291.9K	282.9K
Net Cash Flow	-407.03K	-724.48K	62.87K	141.04K	404.31K	1.01M	257.23K	263.12K	262.94K
Free Cash Flow	-733.53K	-974.48K	-1.06M	-882.06K	-627.79K	-307.17K	-34.67K	-28.78K	-19.95K